Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry

Aim. Treatment practices and effectiveness in cirrhotic patients with hyponatremia (HN) in the HN Registry were assessed. Methods. Characteristics, treatments, and outcomes were compared between patients with HN at admission and during hospitalization. For HN at admission, serum sodium concentration...

Full description

Saved in:
Bibliographic Details
Main Authors: Samuel H. Sigal, Alpesh Amin, Joseph A. Chiodo, Arun Sanyal
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2018/1579508
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547463948402688
author Samuel H. Sigal
Alpesh Amin
Joseph A. Chiodo
Arun Sanyal
author_facet Samuel H. Sigal
Alpesh Amin
Joseph A. Chiodo
Arun Sanyal
author_sort Samuel H. Sigal
collection DOAJ
description Aim. Treatment practices and effectiveness in cirrhotic patients with hyponatremia (HN) in the HN Registry were assessed. Methods. Characteristics, treatments, and outcomes were compared between patients with HN at admission and during hospitalization. For HN at admission, serum sodium concentration [Na] response was analyzed until correction to > 130 mmol/L, switch to secondary therapy, or discharge or death with sodium ≤ 130 mmol/L. Results. Patients with HN at admission had a lower [Na] and shorter length of stay (LOS) than those who developed HN (P < 0.001). Most common initial treatments were isotonic saline (NS, 36%), fluid restriction (FR, 33%), and no specific therapy (NST, 20%). Baseline [Na] was higher in patients treated with NST, FR, or NS versus hypertonic saline (HS) and tolvaptan (Tol) (P < 0.05). Treatment success occurred in 39%, 39%, 52%, 78%, and 81% of patients with NST, FR, NS, HS, and Tol, respectively. Relapse occurred in 55% after correction and was associated with increased LOS (9 versus 6 days, P < 0.001). 34% admitted with HN were discharged with HN corrected. Conclusions. Treatment approaches for HN were variable and frequently ineffective. Success was greatest with HS and Tol. Relapse of HN is associated with increased LOS.
format Article
id doaj-art-ca46a5514115425aa8c6bc4ac8315fe8
institution Kabale University
issn 2291-2789
2291-2797
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology and Hepatology
spelling doaj-art-ca46a5514115425aa8c6bc4ac8315fe82025-02-03T06:44:47ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972018-01-01201810.1155/2018/15795081579508Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia RegistrySamuel H. Sigal0Alpesh Amin1Joseph A. Chiodo2Arun Sanyal3Department of Medicine, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York 10467, USADepartment of Medicine, University of California, Irvine, California 92868, USAAgile Therapeutics, Inc., Princeton, New Jersey 08540, USAVirginia Commonwealth University Medical Center, Richmond, Virginia 23298, USAAim. Treatment practices and effectiveness in cirrhotic patients with hyponatremia (HN) in the HN Registry were assessed. Methods. Characteristics, treatments, and outcomes were compared between patients with HN at admission and during hospitalization. For HN at admission, serum sodium concentration [Na] response was analyzed until correction to > 130 mmol/L, switch to secondary therapy, or discharge or death with sodium ≤ 130 mmol/L. Results. Patients with HN at admission had a lower [Na] and shorter length of stay (LOS) than those who developed HN (P < 0.001). Most common initial treatments were isotonic saline (NS, 36%), fluid restriction (FR, 33%), and no specific therapy (NST, 20%). Baseline [Na] was higher in patients treated with NST, FR, or NS versus hypertonic saline (HS) and tolvaptan (Tol) (P < 0.05). Treatment success occurred in 39%, 39%, 52%, 78%, and 81% of patients with NST, FR, NS, HS, and Tol, respectively. Relapse occurred in 55% after correction and was associated with increased LOS (9 versus 6 days, P < 0.001). 34% admitted with HN were discharged with HN corrected. Conclusions. Treatment approaches for HN were variable and frequently ineffective. Success was greatest with HS and Tol. Relapse of HN is associated with increased LOS.http://dx.doi.org/10.1155/2018/1579508
spellingShingle Samuel H. Sigal
Alpesh Amin
Joseph A. Chiodo
Arun Sanyal
Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry
Canadian Journal of Gastroenterology and Hepatology
title Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry
title_full Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry
title_fullStr Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry
title_full_unstemmed Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry
title_short Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry
title_sort management strategies and outcomes for hyponatremia in cirrhosis in the hyponatremia registry
url http://dx.doi.org/10.1155/2018/1579508
work_keys_str_mv AT samuelhsigal managementstrategiesandoutcomesforhyponatremiaincirrhosisinthehyponatremiaregistry
AT alpeshamin managementstrategiesandoutcomesforhyponatremiaincirrhosisinthehyponatremiaregistry
AT josephachiodo managementstrategiesandoutcomesforhyponatremiaincirrhosisinthehyponatremiaregistry
AT arunsanyal managementstrategiesandoutcomesforhyponatremiaincirrhosisinthehyponatremiaregistry